DHA supplementation and pregnancy outcomes

American Journal of Clinical Nutrition

Volumn 97, Issue 4, 2013, Pages 808-815

  Carlson, Susan E ^a   Colombo, John ^c   Gajewski, Byron J ^b   Gustafson, Kathleen M ^a   Mundy, David ^d   Yeast, John ^d   Georgieff, Michael K ^e   Markley, Lisa A ^a   Kerling, Elizabeth H ^a   Shaddy, D Jill ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; PLACEBO;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FEMALE; HOSPITALIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; PHASE 3 CLINICAL TRIAL; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VERY LOW BIRTH WEIGHT;

ADULT; BIRTH WEIGHT; BODY HEIGHT; DIETARY FATS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; ERYTHROCYTES; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; HEAD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LENGTH OF STAY; PHOSPHOLIPIDS; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; UMBILICAL CORD; YOUNG ADULT;

EID: 84875839172     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.050021     Document Type: Article

References (21)

1. Olsen SF, Joensen HD. High liveborn birth weight in the Faroes: a comparison between birth weights in the Faroes and in Denmark. J Epidemiol Community Health 1985;39:27-32.
2. Campoy C, Escoano-Margarit V, Anjos T, Szajewska H, Uauy R. Omega 3 fatty acids on child growth, visual acuity and neurodevelopment. Br J Nutr 2012;107:S85-106.
3. Larqué E, Gil-Sanchez A, Prieto-Sanchez MT, Koletzko B. Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr 2012;107: S77-84.
4. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction. Cochrane Database of Systematic Reviews 2006;3.
5. Ramakrishnan U, Stein AD, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juarez-Marquez S, Rivera J, Martorell R. Effect of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized double-blind, placebo-controlled trial in Mexico. Food Nutr Bull 2010;31:S108-16.
6. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children. JAMA 2010;304:1675-83.
7. Centers for Disease Control and Prevention. Quick Stats: mean gestational age, by plurality-United States, 2005. MMWR Morb Mortal Wkly Rep 2008;57:225-52.
8. Donahue SMA, Kleinman KP, Gillman MW, Oken E. Trends in birth weight and gestational length among singleton term births in the United States: 1990-2005. Obstet Gynecol 2010;115:357-64.
9. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226:497-509.
10. Zail SS, Pickering A. Fatty acid composition of erythrocytes in hereditary spherocytosis. Br J Haematol 1979;42:399-402.
11. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964;5:600-8.
12. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003;101:469-79.
13. Courville AB, Harel O, Lammi-Keefe CJ. Consumption of a DHAcontaining functional food during pregnancy is associated with lower infant ponderal index and cord plasma insulin concentration. Br J Nutr 2011;106:208-12.
14. Ríos JM, Tufiño-Olivares E, Reza-López S, Sanín LH, Levario-Carrillo M. Birthweight percentiles by gestational age and gender for children in the North of Mexico. Paediatr Perinat Epidemiol 2008;22:188-94.
15. Allen KGD, Harris MA. The role of n23 fatty acids in gestation and parturition. Exp Biol Med (Maywood) 2001;226:498-506.
16. Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T, Drevon CA. Similar effect on infants of n23 and n26 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108 (5):E82.
17. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. BJOG 2000;107:382-95.
18. Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. on behalf of the FOTIP team. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomized clinical trial with fish oil. Eur J Clin Nutr 2007;61:976-85.
19. Harper M, Thom E, Klebanoff M, Thorp J Jr, Sorokin Y, Varner MW, Wapner RJ, Caritis SN, Iams JD, Carpenter MW, et al. Omega-3 fatty acid supplementation to prevent recurrent preterm birth. Obstet Gynecol 2010;115:234-42.
20. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, Mathews TJ, Wilson EC. Births: final data for 2009. Natl Vital Stat Rep 2011;60:1-70.
21. Rasmussen KM, Abrams B, Bodnar LM, Butte NF, Catalano PM, Maria Siega-Riz A. Recommendations for weight gain in pregnancy in the face of the obesity epidemic. Obstet Gynecol 2010;116:1191-5.